Stock Fundamentals

Company Information

Company Name
Pulmonx Corp
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US7458481014
CIK: 0001127537
CUSIP: 745848101
Currency: USD
Full Time Employees: 296
Phone: 650 364 0400
Fiscal Year End: December
IPO Date: Oct 01, 2020
Description:

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Address:

700 Chesapeake Drive, Redwood City, CA, United States, 94063

Directors & Officers

Name Title Year Born
Mr. Glendon E. French CEO, President & Director 1962
Dr. Derrick Sung Ph.D. CFO & COO 1973
Mr. David A. Lehman J.D. General Counsel & Secretary 1961
Mr. Srikanth Radhakrishnan Chief Science & Technology Officer 1973
Ms. Marcee M. Maroney Vice President of Marketing 1970
Ms. Lisa Paul Chief People Officer 1964
Mr. Jérôme Erath Senior VP & GM of International NA
Mr. Geoffrey Beran Rose Chief Commercial Officer 1974
Dr. Narinder S. Shargill Ph.D. Senior Vice President of Global Medical & Clinical Affairs 1955
Mr. John B. McKune VP of Finance & Corporate Controller 1976

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 02, 2026 Geoffrey Beran Rose N/A Sale 7.73K $1.43 $11.06K
Mar 02, 2026 Glendon E French III N/A Sale 67.81K $1.43 $96.97K
Mar 02, 2026 Srikanth Radhakrishnan N/A Sale 10.48K $1.43 $14.99K
Mar 02, 2026 David Aaron Lehman N/A Sale 12.24K $1.43 $17.50K
Dec 01, 2025 David Aaron Lehman N/A Sale 10.28K $1.57 $16.14K
Dec 01, 2025 Geoffrey Beran Rose N/A Sale 6.32K $1.57 $9.93K
Dec 01, 2025 Glendon E French III N/A Sale 8.81K $1.57 $13.82K
Sep 02, 2025 Geoffrey Beran Rose N/A Sale 6.54K $1.60 $10.47K
Sep 02, 2025 Steven S Williamson N/A Sale 9.65K $1.60 $15.44K
Sep 02, 2025 Mehul Joshi N/A Sale 7.94K $1.60 $12.70K
Sep 02, 2025 David Aaron Lehman N/A Sale 9.77K $1.60 $15.63K
Jun 12, 2025 Richard Ferrari N/A Sale 8.00K $3.16 $25.28K
Jun 05, 2025 Daniel P Florin N/A Purchase 23.32K $3.06 $71.36K
Jun 02, 2025 David Aaron Lehman N/A Sale 10.46K $3.13 $32.73K
Jun 02, 2025 Geoffrey Beran Rose N/A Sale 6.95K $3.13 $21.74K
Jun 02, 2025 Mehul Joshi N/A Sale 8.06K $3.13 $25.23K
Jun 02, 2025 Steven S Williamson N/A Sale 9.92K $3.13 $31.06K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
PRIMECAP Management Company 4.72M Mar 31, 2026 11.19% $0.00 -0.06%
Morgan Stanley - Brokerage Accounts 3.99M Mar 31, 2026 9.46% $0.00 -4.01%
Soleus Capital Management, L.P. 2.79M Mar 31, 2026 6.60% $0.15 36.80%
BlackRock Inc 2.66M Mar 31, 2026 6.30% $0.00 -1.65%
Vanguard Group Inc 2.54M Dec 31, 2025 6.01% $0.00 13.31%
ExodusPoint Capital Management, LP 1.94M Mar 31, 2026 4.60% $0.02 -0.38%
Vanguard Capital Management, LLC 1.63M Mar 31, 2026 3.87% $0.00 0.00%
Bank of America Corp 1.17M Mar 31, 2026 2.76% $0.00 60.32%
Deutsche Bank AG 1.16M Mar 31, 2026 2.76% $0.00 3.36%
Geode Capital Management, LLC 944.49K Mar 31, 2026 2.24% $0.00 4.19%
State Street Corp 809.12K Mar 31, 2026 1.92% $0.00 -1.47%
Stonepine Capital Management Llc 768.29K Mar 31, 2026 1.82% $0.40 57.95%
Parkman Healthcare Partners LLC 755.64K Mar 31, 2026 1.79% $0.10 3.83%
BRAIDWELL LP 752.54K Mar 31, 2026 1.78% $0.03 0.00%
Barclays PLC 683.44K Mar 31, 2026 1.62% $0.00 44.72%
Vanguard Portfolio Management, LLC 604.46K Mar 31, 2026 1.43% $0.00 0.00%
JPMorgan Chase & Co 388.10K Mar 31, 2026 0.92% $0.00 -9.06%
ADAR1 Capital Management LLC 374.50K Mar 31, 2026 0.89% $0.03 5.37%
AQR Capital Management LLC 357.58K Mar 31, 2026 0.85% $0.00 506.90%
Northern Trust Corp 354.67K Mar 31, 2026 0.84% $0.00 5.20%

Shares Statistics

Shares Outstanding: 42.24M
Shares Float: 36.97M
% Insiders: 488.50%
% Institutions: 7,882.70%
Short % Float: 3.23%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 PRIMECAP Odyssey Aggressive Growth 3.60M 8.53% ▲ 0.00% Mar 31, 2026
2 Vanguard Total Stock Mkt Idx Inv 1.15M 2.73% ▲ 0.00% Apr 30, 2026
3 iShares Russell 2000 ETF 884.89K 2.10% ▲ 0.93% May 29, 2026
4 Xtrackers S&P 500 Swap ETF 1C 692.75K 1.64% ▼ 0.73% Dec 31, 2025
5 Vanguard US Opportunities Ins USD Acc 666.79K 1.58% ▲ 0.00% Mar 31, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 438.22K 1.04% ▲ 0.00% Apr 30, 2026
7 Xtrackers S&P Global Infra Swap ETF 1C 402.32K 0.95% ▲ 0.00% Dec 31, 2025
8 Vanguard Explorer Inv 383.09K 0.91% ▲ 0.00% Mar 31, 2026
9 Fidelity Small Cap Index 368.25K 0.87% ▼ 1.86% Mar 31, 2026
10 iShares Russell 2000 Growth ETF 308.57K 0.73% ▼ 0.65% May 29, 2026

Valuation Metrics

Enterprise Value: $59.77M
Trailing P/E: 0.00
Forward P/E: 28.33

Financial Highlights

Market Cap: $65.05M
EBITDA: $-51.16M
Book Value: $1.08
Earnings/Share: $-1.30
Profit Margin: -60.09%
Operating Margin: -62.94%
ROA (TTM): -24.04%
ROE (TTM): -86.22%
Revenue (TTM): $88.55M
Revenue/Share (TTM): $2.15
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -8.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.07x 0.71x 0.58x -17.01x -0.78x
2024-12-31 5.58x 0.44x 0.47x -16.45x -0.75x
2023-12-31 6.50x 0.34x 0.33x -19.16x -0.73x
2022-12-31 9.14x 0.13x 0.20x -55.01x -0.37x
2021-12-31 11.85x 0.10x 0.18x -57.06x -0.42x
2020-12-31 19.96x 0.09x 0.14x -10.16x -0.69x
2019-12-31 2.90x -0.08x 4.50x -7.70x -0.92x
2018-12-31 1.40x -0.21x 12.15x -5.97x -2.19x
2017-12-31 3.02x -19.10x 1.04x N/A -0.23x
2016-12-31 0.05x -0.95x 5.91x N/A -1.07x
2015-12-31 1.15x -1.28x 3.64x N/A -1.36x
2014-12-31 0.27x -1.23x 3.99x N/A -1.01x
2013-12-31 0.13x -1.45x 17.92x N/A -2.73x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about LUNG.US!